What is the main business of Bozkam?

The main business activity of Bozkam focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 26, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Nowogrodzka 64, 02-014 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from April 3, 2025 to December 30, 2025.

What revenue was generated?

The company reported a revenue of $0 in 2025.

Is the company profitable?

No, in 2025 the company reported a net loss of $3,066.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $3,066 in 2025, representing 100% of all operating expenses.

Bozkamsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2020-05-26

Share capital

5,000.00 PLN

Registered address

ul. Nowogrodzka 64/43, 02-014 Warszawa, Poland

Electronic delivery address

AE:PL-11788-86832-TDCEU-30

Financials

Revenue history (in k)

Financial insight

The statement flags a going concern risk.

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 683 days for 2022), 1 not filed.

202526/03/2026
2024not filed
202316/04/2025
202228/05/2025
202127/12/2022
202027/12/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 0.10MedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD -3.07kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 3.07kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 53.01kMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Bożena Iwona Kalbarczyk – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations of will concerning property and non-property rights and obligations acting independently.

Ownership

Owner	Shares	Share value	Stake
Bożena Iwona Kalbarczykage 65	90	$1,215.56	90%
Kamil Kalbarczykage 40	10	$135.06	10%

Bożena Iwona Kalbarczyk and Kamil Kalbarczyk hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2020-06-08 to 2026-08-25.

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Black & Whitesp. z o.o.	$154,866.36	polonus.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu
Get Ready Wheelchairssp. z o.o.	$9,842.54	getreadywheelchairs.com
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl
Optimedussp. z o.o.	$1.00	optimedus.pl

Change history

Date	Event
2025-12-30	Business suspended
2025-04-03	Business resumed
2023-04-18	Name change (Medi-Tech → Bozkam)
2023-01-16	Business suspended
2022-03-23	Address change (Ul. Szkolna 5/33, 05-825, Grodzisk Mazowiecki → Ul. Nowogrodzka 64/43, 02-014, Warszawa)

FAQ

Last updated: 2026-03-26